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INTRODUCTION: Visual analysis is widely used to interpret regional cerebral blood flow (rCBF) SPECT images in clinical 
practice despite its limitations. Automated methods are employed to investigate between-group rCBF differences in research studies 
but have rarely been explored in individual analyses. 
OBJECTIVES: To compare visual inspection by nuclear physicians with the automated statistical parametric mapping program 
using a SPECT dataset of patients with neurological disorders and normal control images. 
METHODS: Using statistical parametric mapping, 14 SPECT images from patients with various neurological disorders were com-
pared individually with a databank of 32 normal images using a statistical threshold of p<0.05 (corrected for multiple comparisons 
at the level of individual voxels or clusters). Statistical parametric mapping results were compared with visual analyses by a nuclear 
physician highly experienced in neurology (A) as well as a nuclear physician with a general background of experience (B) who 
independently classified images as normal or altered, and determined the location of changes and the severity. 
RESULTS: Of the 32 images of the normal databank, 4 generated maps showing rCBF abnormalities (p<0.05, corrected). Among 
the 14 images from patients with neurological disorders, 13 showed rCBF alterations. Statistical parametric mapping and physi-
cian A completely agreed on 84.37% and 64.28% of cases from the normal databank and neurological disorders, respectively. 
The agreement between statistical parametric mapping and ratings of physician B were lower (71.18% and 35.71%, respectively). 
CONCLUSION: Statistical parametric mapping replicated the findings described by the more experienced nuclear physician. This 
finding suggests that automated methods for individually analyzing rCBF SPECT images may be a valuable resource to comple-
ment visual inspection in clinical practice.
KEYWORDS: Brain SPECT; ECD; Statistical parametric mapping; Cerebral blood flow; Dementia. 
INTRODUCTION
The technique of single photon emission computed 
tomography (SPECT) is widely used to evaluate regional 
cerebral blood flow (rCBF) patterns in subjects with 
neuropsychiatric disorders. It can be used in neurological 
practice as a valuable tool for different clinical situations, 
such as locating the epileptic focus,1 providing diagnostic 
support for dementia,2 evaluating closed cranial trauma3 and 
assessing cerebrovascular disease.4
In clinical practice, visual inspection has been the 
method most used for analyzing cerebral SPECT images. In 
this approach, the nuclear clinician needs to decide whether 
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the image is normal or abnormal, which structures are 
affected, whether the detected abnormality relates to hypo- 
or hyperperfusion, and the extent and severity of the damage. 
This assessment is essentially carried out subjectively based 
on the reference frame of the individual examining the 
images. Such individual points of reference will generally 
have been acquired through the individual’s own practical 
experience over the course of his/her career. 
However, when visual evaluation is insufficient, 
particularly for cases of borderline findings from cerebral 
SPECT images, a semiquantitative means of evaluation 
based on superposing the regions of interest (ROIs) on 
predefined cerebral structures can be used.5,6 Through this 
approach, mean counts for radioactive substrate uptake 
in the cerebral structures under analysis can be obtained. 
These counts can be compared with the uptake in other brain 
structures taken as normal references, which are chosen 
because they are presumed not to be affected by the disease 
under investigation by cerebral SPECT examination (for 
instance, the cerebellum or occipital cortex would be used as 
a reference). However, analysis by means of ROIs presents a 
variety of methodological problems, such as laboriousness, 
dependence on the observer who delineates the ROIs, the 
impossibility of distinguishing between different activity 
patterns within portions of the same ROI and the induced 
errors that occur when small ROIs are delineated (which 
may lead to failure in identifying foci of abnormalities that 
might not fall within the area delimited by the ROI). 
In recent years, there has been great interest in 
methodologies that allow quantification of cerebral SPECT 
data used to evaluate rCBF patterns more objectively and 
rapidly than ROI-based methods.7,8 The automated method 
for statistical analysis of SPECT images that has been 
rated highest is statistical parametric mapping (SPM).9 
This method was originally designed for use with positron 
emission tomography (PET) images and was subsequently 
adapted for processing cerebral SPECT data. SPM has 
been widely used in studies in which cerebral images from 
groups of patients with a specific diagnosis are compared 
with images from groups of normal volunteers who have 
been matched for demographic variables. For each voxel 
of brain volume, this comparison between groups tests 
the differences between the means of the two sets of data 
while taking the variance within groups into account.10 With 
SPM, statistical comparisons between different subgroups 
of patients can also be made (for example, with different 
types of dementia).11 In addition, regional cerebral function 
patterns among samples of patients can be correlated with 
the severity of specific symptoms by quantifying each voxel 
using standardized scales.12 These statistical analyses are 
computed through several stages of image preprocessing 
including realignment, automatic spatial normalization and 
smoothing. Following these preprocessing stages, statistical 
brain mapping is compiled and evaluated. The result of these 
analyses shows significant foci in a standardized anatomical 
space.9,13
Despite the good results that have been obtained 
using SPM for comparisons between groups in 
neuroscience studies involving the PET and cerebral 
SPECT techniques,14,15 only a few studies have evaluated 
the usefulness of SPM for evaluating individual cases 
in daily practice within nuclear medicine. Automatic 
analysis methods have already been incorporated into 
the clinical routine within nuclear medicine and in other 
medical fields of medical knowledge, specifically nuclear 
cardiology. However, this type of analysis continues to be 
minimally explored in clinical practice within neurology 
and psychiatry. In the first study that evaluated the use of 
an automated analysis method, Signorini et al.16 (1999) 
measured cerebral glucose metabolism using PET after 
administering fluorodeoxyglucose ([18F]FDG) to six patients 
with different brain-based neurological disorders (ND). The 
images from each patient were statistically contrasted with 
images from a pool of nineteen normal controls to generate 
individual statistical maps showing the locations of the 
cerebral metabolic abnormalities in each patient. Subsequent 
studies further demonstrated potential clinical usefulness of 
SPM for objective evaluation of the locations of epileptic 
foci in SPECT (rCBF)17,18 and PET19 images, as well as 
for evaluation of patients with closed cranial trauma using 
cerebral SPECT.20 
One particularly important but still little-investigated 
issue is the verification of the degree of concordance 
between visual assessments made by nuclear medicine 
clinicians and the results obtained automatically using 
SPM to evaluate individual PET or cerebral SPECT 
examinations.16,21,22 For example, no cerebral SPECT study 
has yet investigated whether any differences exist in the 
degree of concordance between visual assessments and 
the statistical map generated by SPM in individual cases. 
Furthermore, no study has addressed this question in relation 
to the degree of experience of the nuclear medicine clinician 
performing the visual inspection. Demonstrating differences 
in concordance between clinicians with different levels of 
experience and the automated method might strengthen the 
usefulness of SPM for assisting general clinicians within 
nuclear medicine. 
In the present study, we analyzed images from patients 
who had undergone evaluations using cerebral SPECT 
to support diagnoses of ND. We used automated SPM 
evaluations and visual assessments of two clinicians with 
different degrees of experience in inspecting cerebral SPECT 
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data. The two aims of this study were (1) to ascertain the 
frequency of concordance between visual and automated 
evaluations so as to demonstrate the degree of usefulness 
of SPM for representing perfusion abnormalities and 
(2) to evaluate the possible differences in the degree of 
concordance between SPM and the two clinicians. Our 
working hypothesis was that the automated method would 
present a greater degree of concordance with the visual 
assessment of the more experienced clinician.
MATERIAL AND METHODS
SPECT images from the group of patients with neuro-
logical disorders 
Fourteen cerebral SPECT images were selected from a 
database of patients who had been referred to the Nuclear 
Medicine Service of the Heart Hospital of Associação do 
Sanatório Sírio, in São Paulo, Brazil (HCor). The images 
were from 4 men and 10 women of ages ranging from 37 
to 87 years [mean = 66.5 years; standard deviation (SD) 
= 10.33]. These patients had been referred by experienced 
clinical neurologists and neuropsychiatrists in the city of São 
Paulo who requested the image evaluation as complementary 
support for the clinical diagnosis. In most cases (n=4 
subjects), the suspicion that motivated the request for 
SPECT examination was a condition of dementia, generally 
Alzheimer’s disease. Among the remaining images (n= 5 
subjects), the suspected diagnoses were fronto-temporal 
dementia (n=1), neurocysticercosis (n=1), cerebral tumor 
(n=1) and stroke (n=2). 
SPECT images from the control group
A database of 32 cerebral SPECT images was created 
from individuals who were presumed not to have cerebral 
abnormalities. The images were from 15 men and 17 
women of ages ranging from 26 to 84 years, with a mean 
age of 44.5 years (SD = 16.004). Two different sources 
were used to compile this database. The first source was 
a control group of healthy volunteers (n = 26) who were 
recruited for a SPECT study conducted by Busatto et al.14 
(2000). From this group, 21 individuals over the age of 20 
years were selected to approximately match the age groups 
of subjects with ND described above. Before undergoing 
the SPECT examination, all subjects in this control group 
underwent a detailed assessment, including general medical 
anamnesis and the structured clinical interview for DSM-IV 
diagnosis of psychiatric disorders (SCID23), to rule out the 
presence of any neurological and/or psychiatric disorders. 
Moreover, these individuals showed no signs of gross brain 
abnormalities, as assessed by structural magnetic resonance 
scans that were visually inspected by two radiologists 
independently from each other. The second source for the 
control database was individuals who had been examined 
at the Nuclear Medicine Service of HCor to clarify the 
diagnosis in cases of complaints of headache or temporary 
memory deficit. Eleven cerebral SPECT images from these 
subjects were selected for the control data set. These had 
been assessed as showing a normal visual appearance, 
without any abnormalities, by a nuclear clinician who 
was highly experienced in evaluating cerebral SPECT 
examinations (C.A.B.). 
Protocol for acquisition and processing of cerebral 
SPECT images
The protocols used for acquisition and processing of 
cerebral SPECT data were similar for all subjects in the 
above groups. After venous puncture in a superficial vein 
of the arm, the individuals remained at rest for 20 minutes 
and then received a dose of 740 MBq of 99mTc-ECD. Image 
acquisition began after another 30 minutes. All examinations 
were performed using a device with two detectors and high-
resolution collimators (OPTIMA NX, General Electric, 
Milwaukee, USA). The images were acquired using the step-
and-shoot method. A matrix of 128 X 128 was used, and 128 
projections were acquired (20 seconds per projection).
The orbital-meatal line was used for reconstruction 
of the SPECT images, which was done using the filtered 
back-projection method with attenuation correction in 
accordance with Chang’s algorithm (m=0.12 cm-1). All 
images were reconstructed with 2.25 mm pixels and a tenth-
order Butterworth filter with Nyquist frequency of 0.57. 
Transverse sections through the reconstructed images were 
selected for the subsequent stages of the analysis. 
Protocol for visual inspection of the SPECT images
For the visual analysis, two nuclear clinicians with 
different experience levels from recognized institutions 
in the city of São Paulo were invited to participate. One 
of these physicians (clinician A) was highly experienced 
in analyzing neurofunctional images acquired using 
the SPECT method, while the other (clinician B) was 
experienced in general nuclear medicine, without specific 
expertise in brain SPECT image analysis. The clinicians 
were positioned in front of a computer monitor and the 
images (both normal and abnormal) were shown without 
identification and randomly. The clinicians remained blind 
to the clinical data related to the images under examination 
and were asked to record whether the image was normal 
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or abnormal. If the image was considered to show any 
rCBF abnormality, the clinicians were asked to indicate 
its location, severity (mild, moderate or severe), extent 
of damage (partial or complete) and any involvement of 
adjacent cerebral structures.
Generation of individualized statistical parametric 
maps showing rCBF abnormalities
Individualized statistical parametric maps for each 
subject were produced using the SPM program, version 
1999, executed in MATLAB 4.2. First, SPECT images of 
all patients with ND and controls were spatially normalized 
with linear 12-point affine transformations to an anatomical 
template provided by the SPM program, which approximates 
the stereotaxic space of the Talairach-Tournoux24 atlas. Next, 
images were re-sliced using bi-linear interpolation to a final 
voxel size of 2 x 2 x 2 mm3 and smoothed with an isotropic 
Gaussian filter (12 mm full-width at half maximum) to 
improve the signal-to-noise ratio and to reduce errors 
attributed to inter-individual variations in gyral and sulcal 
anatomy. For each of the subjects with ND (n=14), a voxel-
by-voxel t-test map was obtained by comparison against the 
pool of controls (n=32). For the purpose of accounting for 
inter-individual differences in overall cerebral blood flow, 
the regional 99mTc-ECD uptake was standardized to the mean 
overall uptake using proportional scaling. The measure of 
total brain radioactive uptake was obtained automatically 
from the SPM program in terms of the mean counts of 
all voxels included in the SPECT volume of each subject, 
after the spatial transformations described above. Given the 
significant difference between the mean age of the control 
group (44.5 +/- 16 y) and that of the ND group (66.5 +/- 
10.33 y), age was used as a confounding covariate in the 
individual analyses conducted for all patients. To reduce the 
number of statistical comparisons, only voxels with signal 
intensities above 50% of the mean overall value were entered 
into each analysis. The individualized SPM{t} maps for each 
subject were transformed to a normal distribution (Z scores), 
thresholded at 3.09 (corresponding to ρ<0.001, uncorrected 
for multiple comparisons) and displayed as statistical 
parametric maps in standard space. The same procedure was 
carried out to provide individualized statistical parametric 
maps of rCBF abnormalities for the control subjects by 
comparing each control individual against the remaining 31 
subjects.
Clusters of rCBF abnormalities in the individualized 
maps were then examined in terms of size (k) and peak 
height (u) and were considered significant only if they 
retained statistical significance after correction for multiple 
comparisons based on Gaussian random field theory 
(p<0.05), either at the level of individual voxel height or at 
the level of clusters25. 
Criteria for evaluating the concordance between the 
clinicians and SPM
For each image evaluated by the two clinicians, criteria 
were established for applying concordance scores ranging 
from 0 to 3. A score of 0 (complete disagreement) was 
applied if one of the evaluators considered the image to be 
normal while the other found abnormalities of any nature 
in the rCBF profile. A score of 1 was given if the evaluators 
agreed that the image was abnormal, but disagreed about 
which cerebral structures were affected. A score of 2 
was given for other situations of partial agreement (they 
agreed about which region was affected but also noted 
another different region or they disagreed on the extent 
of the abnormality or the hemisphere). Finally, a score of 
3 indicated complete agreement regarding the location, 
extent and severity of the rCBF abnormalities detected 
by the two evaluators. Based on the scores obtained using 
these criteria, the general percent concordance between the 
two clinicians was calculated both for the entire sample of 
patients with ND and control individuals, and separately for 
these two groups of subjects. The same criteria were applied 
to evaluate the percent concordance between each of the two 
clinicians separately and the individualized statistical maps 
obtained using the SPM software. 
Finally, with the aim of investigating possible statistically 
significant differences in the degree of concordance that 
the evaluators had with SPM, comparisons between the 
respective scores were made using the chi-square test 
(at a significance level of p < 0.05). These analyses were 
performed using the scores obtained for the entire sample of 
patients with ND and control individuals, and separately for 
these two groups. 
RESULTS
Automated analysis using SPM
Among the images from the control group, 4 of the 
32 subjects presented at least one region of the brain with 
abnormal rCBF according to the analyses carried out using 
SPM (in individualized analyses comparing one subject with 
all others) using a threshold of statistical significance defined 
for this study (p < 0.05; corrected for multiple comparisons 
at individual voxel level or cluster level). Three of these 
images came from “source 1”, which consisted of young 
adults who had been screened prospectively to exclude 
general medical conditions and neuropsychiatric disorders. 
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With the automated analysis using SPM to compare 
each of the 14 ND subjects with the above pool of normal 
controls, statistically significant foci for rCBF abnormalities 
were identified in 13 cases. Nine of these abnormalities met a 
significant threshold of p<0.05 and were corrected for multiple 
comparisons at individual voxel level or cluster level, while 4 
were significant only at the cluster level (Table 1).
Frequency of concordance in visual inspection between 
the two nuclear medicine clinicians
Table 2 lists the findings regarding agreement and 
disagreement in visual inspection between the two nuclear 
medicine clinicians for examinations of previously 
identified subjects with ND (n=14). In this group, the two 
clinicians agreed completely on 7 assessments (50%), 
partially agreed on 4 (28.7%) and disagreed on 3 (21.4%). 
For examinations of the control group (n=32), the two 
clinicians agreed completely on 25 of the 32 subjects (75%). 
Clinician A considered 27 SPECT images to show no rCBF 
abnormalities, while clinician B interpreted 23 of the same 
images as normal (Table 2). 
Frequency of concordance between the visual inspec-
tion of the two clinicians and the automated analysis 
using SPM
As shown in Table 3, the visual assessment of clinician 
A showed complete agreement with the result from the 
individual maps generated by SPM for 27 of the 32 images 
from the control group (84.37%), and disagreed for 5 of the 
32 images. Clinician A indicated that 29 were normal. In 
contrast, the visual inspection of clinician B agreed with the 
analysis using SPM to a lesser degree in the control group, 
agreeing for only 23 of the 32 subjects (71.18%) (Table 3) 
and disagreeing for 9 subjects. Clinician B found that 26 of 
the images were normal. 
Among the group of patients with ND, there was 
complete agreement between the visual inspection of 
clinician A and the automated analysis using SPM in 9 
cases, with 2 partial agreements and 3 disagreements 
(Table 3; Figure 1). Between clinician B and SPM, there 
were 5 complete agreements, 4 partial agreements and 5 
disagreements (Table 3). Thus, the visual inspection of 
clinician A agreed more frequently with the analysis using 
Table 1 - Results from individual analyses using the statistical parametric mapping (SPM) method for patients with neuro-
logical disorders (n = 14)
Subjects Clinical diagnostic 
hypothesis
Age Z max P corrected to indi-
vidual voxel level
P corrected to 
cluster level
Number of 
voxels
Location
1 CVD 80 3.92 0.453 0.03 401 Middle occipital
2 AD 58 6.0 0.000 0.000 6086 Right posterior 
parietal
3 CVD 65 4.06 0.318 0.263 Superior frontal 
4 AD 64 6.07 0.000 0.000 3156 Right middle 
temporal 
5 AD 73 5.07 0.01 0.000 5067 Right inferior 
temporal 
6 AD 66 4.93 0.013 0.055 1242 Right inferior 
temporal 
7 CVD+AD 68 7.42 0.000 0.000 2789 Right central 
posterior parietal
8 AD 69 7.11 0.000 0.000 1351 Right parietal
9 FTD 77 3.47 0.09 0.510 136 Right middle 
frontal 
10 NC 37 4.85 0.021 0.002 918 Left occipital
11 AD 65 5.99 0.000 0.000 4603 Right middle 
temporal 
12 AD 61 3.91 0.459 0.035 Superior parietal
13 TD 79 6.39 0.000 0.000 4699 Left inferior 
frontal
14 PAD 70 5.80 0.000 0.000 968 Right inferior 
temporal
AD: Alzheimer’s disease; FTD: fronto-temporal dementia; CVD: cerebrovascular disease; TD: tumoral disease; NC: neurocysticercosis
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SPM than did the visual inspection of clinician B (64.28% 
concordance with SPM for clinician A versus 35.71% for 
clinician B). 
The statistical evaluation of the frequencies of 
concordance between the clinicians and SPM using the chi-
square test showed no statistically significant differences 
when considering the entire pool of images (n = 46 with 
p = 0.192) or when considering either the patients with ND 
(n = 14 with p = 0.315) or the control group (n = 32 with 
p = 0.364).
DISCUSSION
The results reported in this study confirm previous 
findings that it is possible to use automated methods for 
voxel-by-voxel analysis of rCBF abnormalities in SPECT 
images to evaluate individual cases in clinical practice.16,21,22 
This conclusion is based on the high frequency with which 
our automated analyses using SPM software reproduced 
the rCBF abnormalities detected by the nuclear medicine 
clinicians in patients with ND and also on the low frequency 
Table 2 - Concordance between the findings of visual inspection by clinician a (more experienced in neurology) and clinician b (general medical experi-
ence) 
Groups Complete agreement
n (%)
Partial agreement
n (%)
Complete disagreement
n (%)
∑
n (%)
Patients with neurological 
disorders
7 (50.0) 4 (28.7) 3 (21.4) 14 (100)
Control group 24 (75.0) – (–) 7 (25.0) 32 (100)
Table 3 - Concordance between the findings from visual inspection by clinicians a and b and the results from individualized maps generated by the spm 
software 
 
Group of images Complete agreement 
(n)
Partial agreement (n) Complete 
disagreement (n)
% concordance S images P(χ2)
Control group
Clinician A versus SPM 27 0 5 84.37 32 0.364
Clinician B versus SPM 23 0 9 71.18 32
Patients with neurological 
disorders
Clinician A versus SPM 9 2 3 64.28 14 0.315
Clinician B versus SPM 5 4 5 35.71 14
Figure 1A - Statistical parametric maps on three axes showing cerebral 
areas of hypoperfusion in a 65 year-old patient with a diagnostic hypothesis 
of Alzheimer’s Disease in comparison with the pool of 32 control subjects 
using a statistical threshold of p < 0.001
Figure 1B - Cerebral SPECT image from the same patient showing biparietal-
temporal perfusion deficits similar to the result from the SPM map. From 
the visual inspection, the two evaluators reported the same findings as seen 
on the map produced by the SPM software
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with which functional brain abnormalities were observed for 
individual statistical parametric maps in the control group 
subjects. 
To date, few studies on cerebral SPECT have explored 
the question of the degree of concordance between visual 
evaluations by nuclear medicine clinicians and results 
from statistical maps obtained using automated software 
like SPM. In one of the few studies in which SPM was 
used to evaluate individual images, Barnes et al.21 (2000) 
investigated the impact of adding individual maps generated 
with SPM to clinicians’ decision-making processes after 
these clinicians had visually inspected cerebral SPECT 
images from patients with suspected dementia (n = 9). That 
study demonstrated that the clinicians did not modify their 
initial reports after having had access to the results from 
SPM. Moreover, the degree of concordance between the 
visual evaluations and SPM was only marginal (Barnes 
et al., 2000). In another study in which 15 patients with 
Alzheimer’s disease and 20 with Lewy body dementia were 
evaluated, the individual maps generated using SPM were 
shown to be significantly more accurate than visual analysis 
for both diagnostic categories. SPM detected more areas 
with rCBF abnormalities, particularly in the precuneus and 
medial temporal cortex.22
In contrast to the previous investigations cited above, the 
frequency of concordance between the visual assessments by 
clinicians and the results from maps obtained using the SPM 
software was high in our study. This was especially true for 
evaluation by the nuclear medicine clinician with greater 
neuropsychiatry experience. These results indicate that 
automated methods like SPM for rapid objective analysis 
of rCBF abnormalities in SPECT images have clinical 
validity. However, it should be considered that manipulation 
of the SPM package demands basic knowledge about image 
processing methods and routines of the MATLAB program 
and, therefore, should preferentially be used under the 
supervision of trained computer scientists. The need for 
such specialized staff may prevent more disseminated use 
of SPM in busy nuclear medicine services mainly dedicated 
to clinical work. 
The difference in the degree of concordance of the visual 
assessments with SPM between the two clinicians was 
consistent with the hypothesis of our study; we predicted 
that clinician A (with greater experience) would produce a 
greater proportion of concordant findings, which is what we 
found. This demonstration of differences in concordance 
between clinicians with different backgrounds and the 
automated method emphasizes the usefulness of automated 
methods like SPM as an auxiliary tool for general clinicians 
within nuclear medicine. However, possibly because of the 
size of the sample, the better performance by clinician A did 
not result in statistically significant differences according to 
the chi-square test. 
SPM on neurofunctional images of individual cases is an 
approach of interest because automated methods are already 
widely used in other specialties. For example, within nuclear 
cardiology, this method contributes to the interpretation 
of myocardial perfusion examinations.26 Paralleling the 
application of SPM in routine clinical practice within nuclear 
cardiology, our study used this technique to evaluate a wide 
spectrum of brain perfusion abnormalities, which implies 
that the method reproduced the abnormalities seen by 
clinician A for many different brain perfusion abnormalities. 
Therefore, this method has significant potential in practical 
application to clinical practice when evaluating subjects with 
a large variety of perfusion abnormalities.
One methodological feature of interest was that a 
minority of the subjects in the control group presented 
foci of rCBF abnormalities on the maps generated using 
SPM. Among the four images from the control image 
database that presented some type of abnormality, the 
first three belonged to “source 1”, which was the pool of 
images from screened normal volunteers who were selected 
through rigorous interviews and clinical assessments.14 It 
should be emphasized that all individuals in this group also 
underwent structural magnetic resonance examination and 
no anatomical abnormalities were found after evaluation 
by two radiologists. In view of these screening conditions, 
it is tempting to consider that the rCBF abnormalities 
observed on the statistical maps generated for these 
normal individuals might be related to artifacts in the data 
acquisition or analysis process and not to cerebral functional 
abnormalities. Signorini et al.16 (1999) sought to validate the 
use of SPM for individual analysis of FDG-PET images and 
also observed abnormalities on maps generated for some of 
the normal volunteers included in the control group. These 
artifacts may appear as widening of the cortical sulcus or 
asymmetry between the brain hemispheres. In cerebral 
functional images from elderly individuals, it has been 
demonstrated that maps generated using SPM may show 
artifactual abnormalities that are possibly related to localized 
cerebral atrophy.27-29 This type of finding indicates that 
nuclear medicine clinicians need to be alert to the possibility 
of artifactual rCBF abnormalities in cerebral SPECT images, 
even in normal individuals. The data from the present 
study, along with previous investigations in the literature,16 
indicate that the SPM method is sensitive towards detecting 
this type of abnormality in asymptomatic individuals. This 
observation reinforces the argument that SPM, like other 
automated methods for analyzing brain images, should not 
be used for more than indicating which structures on the 
maps have a greater likelihood of presenting some type of 
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functional abnormality. It is the clinician’s responsibility, 
after careful analysis of the region that has been indicated 
as abnormal and correlation with the clinical condition, to 
decide how such abnormalities should be interpreted. 
It should be noted that construction of individual 
statistical maps using SPM is not the only methodological 
strategy for using automated methods to analyze cerebral 
SPECT data in clinical practice. For instance, alternative 
analysis methods have been developed to support the 
diagnosis of neuropsychiatric conditions, enabling fully 
automated categorization of individual structural or 
functional brain images based on machine-learning 
techniques such as support vector machines (SVMs).30,31 
The SVM approach is a supervised classification method, 
including a ‘training step’ on differences between the groups 
to be classified. Individual scans are then compared with 
trained datasets to be categorized as member of a particular 
group. Recent studies have demonstrated the reliability and 
validity of SVM-based techniques as well as their good 
diagnostic performance in discriminating, for instance, 
between Alzheimer’s disease patients and healthy control 
individuals.31
One important limitation of the present study is that 
we did not use a design that afforded information on the 
differences between the capacity of physicians A versus B to 
reach the correct diagnoses of the diseases investigated, with 
or without SPM support.21,32 Due to that limitation, it is not 
possible to ascertain whether use of the automated approach 
helped physician B reach the correct diagnoses to a greater 
extent than physician A. Future studies should evaluate 
this issue to further ascertain the clinical implications of 
incorporating automated brain image analysis methods to the 
clinical repertoire of nuclear medicine physicians.
In conclusion, the results of the present study indicate 
that the use of automated methods to perform statistical 
comparisons between multiple-detector SPECT data 
from a single subject and a control group of healthy 
volunteers presented a good degree of concordance with 
the visual assessment by a clinician highly experienced 
in the evaluation of brain images, both for detecting 
abnormalities among patients with ND and for inspecting 
SPECT images without apparent abnormalities. This 
observation suggests that statistical maps based on voxel-
by-voxel analysis methods may have practical application 
in routine clinical practice within nuclear neurology, thereby 
benefitting clinicians with less experience in interpreting 
neurofunctional images. 
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